Diallyl disulfide suppresses proliferation and induces apoptosis in human gastric cancer through Wnt-1 signaling pathway by up-regulation of miR-200b and miR-22

H Tang, Y Kong, J Guo, Y Tang, X Xie, L Yang, Q Su… - Cancer letters, 2013 - Elsevier
The purpose of this study was to identify a mechanism related to miRNA pathway which
plays a role in the anti-tumor effects of Diallyl disulfide. Alterations in miRNA expression …

MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4

J Li, Y Guo, X Liang, M Sun, G Wang, W De… - Journal of cancer …, 2012 - Springer
Aims The aim of this study was (a) to determine the role of micro-223 (miR-223) in gastric
cancer and (b) to elucidate its regulatory mechanism on the FBXW7/hCdc4 gene. Materials …

Gastric biomarkers: a global review

N Baniak, JL Senger, S Ahmed, SC Kanthan… - World journal of surgical …, 2016 - Springer
Background Gastric cancer is an aggressive disease with a poor 5-year survival and large
global burden of disease. The disease is biologically and genetically heterogeneous with a …

Nanogap‐rich Au nanowire SERS sensor for ultrasensitive telomerase activity detection: Application to gastric and breast cancer tissues diagnosis

G Eom, H Kim, A Hwang, HY Son… - Advanced functional …, 2017 - Wiley Online Library
Telomerase has attracted much attention as a universal cancer biomarker because
telomerase is overexpressed in more than 85% of human cancer cells while suppressed in …

Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer

MH Kang, H Choi, M Oshima, JH Cheong, S Kim… - Nature …, 2018 - nature.com
The principle factors underlying gastric cancer (GC) development and outcomes are not well
characterized resulting in a paucity of validated therapeutic targets. To identify potential …

[HTML][HTML] The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis

H Xia, Q Chen, Y Chen, X Ge, W Leng, Q Tang… - Oncotarget, 2016 - ncbi.nlm.nih.gov
The metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is frequently over-
expressed and serves as a prognostic marker in human cancers. However, little is known …

Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer

P Stahl, C Seeschaaf, P Lebok, A Kutup… - BMC …, 2015 - Springer
Background Intra-tumor heterogeneity is a potential cause for failure of targeted therapy in
gastric cancer, but the extent of heterogeneity of established (HER2) or potential (EGFR …

Clinical evaluation of CEA, CA19-9, CA72-4 and CA125 in gastric cancer patients with neoadjuvant chemotherapy

Z Sun, N Zhang - World journal of surgical oncology, 2014 - Springer
Background In the clinical practice of neoadjuvant chemotherapy, response markers are
very important. We aimed o investigate whether tumor markers CEA (carcino-embryonic …

LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer

HT Liu, RR Ma, BB Lv, H Zhang, DB Shi, XY Guo… - British journal of …, 2020 - nature.com
Background Accumulating evidence demonstrated that long noncoding RNAs (lncRNAs)
played important regulatory roles in many cancer types. However, the role of lncRNAs in …

Intraperitoneal chemotherapy for unresectable peritoneal surface malignancies

NAD Guchelaar, BJ Noordman, SLW Koolen, B Mostert… - Drugs, 2023 - Springer
Malignancies of the peritoneal cavity are associated with a dismal prognosis. Systemic
chemotherapy is the gold standard for patients with unresectable peritoneal disease, but its …